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Background: Baker’s asthma is among the most important occupational allergic 
diseases. Wheat lipid transfer protein (LTP) Tri a 14 has been reported as a major 
allergen associated with wheat allergy. No panel of wheat recombinant allergens for 
component-resolved diagnosis of baker’s asthma is currently performed. We sought to 
evaluate the potential role of recombinant Tri a 14 as a novel tool for the diagnosis of 
baker’s asthma, and to test the heat and proteolytic resistance of this wheat LTP 
allergen. 
Methods: A cDNA encoding Tri a 14 was isolated and sequenced, the recombinant 
allergen produced in Pichia pastoris and purified by chromatographic methods. 
Physicochemical and immunological comparison of the natural and recombinant forms 
of Tri a 14 was carried out by N-terminal amino acid sequencing, matrix-assisted laser 
desorption/ionization mass spectrometry, circular dichroism analysis, IgE 
immunodetection, and specific IgE determination and ELISA-inhibition assays using a 
pool or individual sera from 26 patients with baker’s asthma. Thermal denaturation and 
simulated gastrointestinal digestion of both Tri a 14 forms were checked by 
spectroscopic and electrophoretic methods, respectively, and biological activity by 
basophil activation test (BAT). 
Results: Natural and recombinant Tri a 14 were similarly folded, as indicated by their 
nearly identical CD spectra and heat denaturation profiles. A high correlation (r=0.77) 
was found between specific IgE levels to both Tri a 14 forms in individual sera from 
baker’s asthma patients, but a slightly lower IgE-binding potency of rTri a 14 was 
detected by ELISA-inhibition assays. Natural and recombinant Tri a 14 elicited positive 
BAT in 2 and 1 out of 3 patients, respectively. Heat denaturation profiles and simulated 
gastrointestinal digestion assays indicated that Tri a 14 displayed a high heat and 
digestive proteolytic resistance, comparable to those of peach Pru p 3, the model food 
allergen of the LTP family. 
Conclusions: Recombinant Tri a 14 is a potential tool for baker’s asthma diagnosis, 
based on its physicochemical and immunological similarity with its natural counterpart, 
and major wheat allergen nTri a 14. 
 
